Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
Mijia Lu, Michelle Chamblee, Yuexiu Zhang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 35
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

The role of vaccines in the COVID-19 pandemic: what have we learned?
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 38
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7
A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice
Jie Liu, Jie Sun, Xue Ding, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective
Yuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines
Yong‐Sik Bong, David Alan Brown, Ezra Chung, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Skin Patch Delivery of a SARS-CoV-2 Spike DNA Vaccine Produces Broad Neutralising Antibody Responses.
Christopher L. D. McMillan, Andrea V. Corner, Danushka K. Wijesundara, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42533-e42533
Open Access
Stabilizing Prefusion SARS-CoV-2 Spike by Destabilizing the Postfusion Conformation
Debajyoti Chakraborty, Randhir Singh, Raju S. Rajmani, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 315-315
Open Access
Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity
James A. Williams, Marco Biancucci, Laura N. Lessen, et al.
Science Advances (2023) Vol. 9, Iss. 23
Open Access | Times Cited: 12
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
Tao Ni, Luiza Mendonça, Yanan Zhu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107882-107882
Open Access | Times Cited: 10
S–6P exhibits better immunogenicity than S–2P at lower doses of COVID-19 mRNA vaccines
Zhongyi Zhu, Lei Zhang, Shuang-Bao Li, et al.
Decoding Infection and Transmission (2024) Vol. 2, pp. 100017-100017
Open Access | Times Cited: 3
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model
Swayam Prakash, Nisha R. Dhanushkodi, Mahmoud Singer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Beyond COVID-19: the promise of next-generation coronavirus vaccines
Reshma Koolaparambil Mukesh, Claude Kwe Yinda, Vincent J. Munster, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Strategies for the Management of Spike Protein-Related Pathology
Matthew Halma, Christof Plothe, Paul E. Marik, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1308-1308
Open Access | Times Cited: 9
Structural understanding of SARS-CoV-2 virus entry to host cells
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 9
The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming
Giulia Paiardi, Matheus Ferraz, Marco Rusnati, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 43
Open Access | Times Cited: 2
Mass photometry reveals SARS-CoV-2 spike stabilisation to impede ACE2 binding through altered conformational dynamics
Sean A. Burnap, Weston B. Struwe
Chemical Communications (2022) Vol. 58, Iss. 93, pp. 12939-12942
Open Access | Times Cited: 12
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery
Cuiping Liu, Lingshu Wang, Jonah S. Merriam, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 7
Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster
Jitender, B. Vikram Kumar, Sneha Singh, et al.
Vaccine (2024) Vol. 42, Iss. 20, pp. 126099-126099
Closed Access | Times Cited: 2
Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
Jianzhong Zhang, Yutian Xia, Xuan Liu, et al.
Bioengineering (2023) Vol. 10, Iss. 2, pp. 148-148
Open Access | Times Cited: 6
Structure-guided design of a trivalent nanobody cluster targeting SARS-CoV-2 spike protein
Xinyi Jiang, Qin Qin, Haixia Zhu, et al.
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128191-128191
Closed Access | Times Cited: 6
Comparative spatial transcriptomic profiling of severe acute respiratory syndrome coronavirus 2 Delta and Omicron variants infections in the lungs of cynomolgus macaques
Taehwan Oh, Green Kim, Seung Ho Baek, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 5
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern
Jiayu Xu, Yuexiu Zhang, Panke Qu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 41
Open Access | Times Cited: 5
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Baskar Balakrishnan, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 1
The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming
Giulia Paiardi, Matheus Ferraz, Marco Rusnati, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Cryo-electron microscopy in the study of virus entry and infection
Moumita Dutta, Priyamvada Acharya
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top